3179. Deputy Naoise Ó Muirí asked the Minister for Health if her Department has considered reimbursement pathways for GLP-1 therapies in obesity where clinically indicated; and if she will make a statement on the matter. [26338/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions under the heading Medicinal Products.
1,228 questions match, newest first.
3203. Deputy Peadar Tóibín asked the Minister for Health the plans to allow recipients of prescribed medicinal cannabis in the North to legally carry and use their medicine in the State (details supplied). [26439/26]
3206. Deputy Pat Buckley asked the Minister for Health if she will ensure that the HSE urgently prioritizes a conclusion to the skyclarys reimbursement negotiations, given that it is the only available treatment for Friedreich's ataxia, which currently can be classed as having an ‘unmet need’ as outlined in the National Rare Disease Strategy 2025-2030. [26466/26]
3207. Deputy Pat Buckley asked the Minister for Health her views on whether the current delay aligns with the "equitable access" promised in the newly launched National Rare Disease Strategy 2025-2030. [26467/26]
3211. Deputy Ruth Coppinger asked the Minister for Health to prioritise the negotiations for reimbursement of a particular drug given that it is the only treatment for a specific disease (details supplied); and if she will make a statement on the matter. [26478/26]
3224. Deputy Ruth Coppinger asked the Minister for Health if she will take steps to ensure that skyclarys (omaveloxolone) is made available for those with Fredericks ataxia who require it; and if she will make a statement on the matter. [26512/26]
3237. Deputy Pádraig Rice asked the Minister for Health further to Parliamentary Question No. 685 of 19 February 2026, if she is committed to implementing Ava's protocol, recommended by Cork City Coroner's office in 2024; if this recommendation will be examined by the Review of Access to Cannabis for Medical Use; and if she will make a statement on the matter. [26568/26]
3239. Deputy Mairéad Farrell asked the Minister for Health further to Parliamentary Question No.1818 of 18 March 2026, if she will intervene to ensure that the HSE urgently prioritises a conclusion to the skyclarys reimbursement negotiations, given that it is the only available treatment for this progressive disease, which currently can be classed as having an 'unmet need' as outlined in the National Rare Disease Str…
3240. Deputy Mary Lou McDonald asked the Minister for Health the specific steps that are being taken to ensure the HSE considers the time-critical nature of the 2026 IPHA Framework Agreement during the current price negotiations for Skyclarys; and the way in which the commitments in the National Rare Disease Strategy 2025-2030 and the 2026 IPHA Framework Agreement, which aims for a 180-day decision timeline, are bein…
3347. Deputy Sean Fleming asked the Minister for Health to outline the process where a person has been on medication (details supplied) and requires specific medical services/medication for their condition; and if she will make a statement on the matter. [27003/26]
3358. Deputy Robert O'Donoghue asked the Minister for Health if she will intervene to ensure that the HSE urgently concludes reimbursement negotiations for skyclarys given that it is currently the only available treatment for Friedreich’s ataxia and that the condition may be considered an unmet need under the National Rare Disease Strategy 2025–2030; and if she will make a statement on the matter. [27037/26]
3359. Deputy Robert O'Donoghue asked the Minister for Health to provide a clear timeline for the conclusion of the reimbursement process for skyclarys given that more than 80 Parliamentary Questions have already been raised on this matter without any indication of when a decision may be reached; and if she will make a statement on the matter. [27038/26]
3366. Deputy Willie O'Dea asked the Minister for Health when the drug sando-K will be available on the medical card for a person (details supplied); and if she will make a statement on the matter. [27087/26]
462. Deputy Pádraig Rice asked the Minister for Health to provide a list of ICS–formoterol combination inhalers currently reimbursed under the general medical services (GMS) scheme, including whether they are approved for use as maintenance and reliever therapy (MART); and if she will make a statement on the matter. [23298/26]
463. Deputy Pádraig Rice asked the Minister for Health to estimate the annual cost to the State of extending reimbursement to provide ICS–formoterol combination inhalers, used as maintenance and reliever therapy (MART), to all children aged 12 to 17 years-of-age diagnosed with asthma; and if she will make a statement on the matter. [23299/26]
473. Deputy Albert Dolan asked the Minister for Health the number of schools currently registered under the Medicines for Listed Organisations framework to hold emergency medicines such as adrenaline auto-injectors for the treatment of severe allergic reactions; and if she will make a statement on the matter. [23373/26]
479. Deputy Danny Healy-Rae asked the Minister for Health if prescription medications are covered on the medical card and drugs refund scheme (details supplied); and if she will make a statement on the matter. [23415/26]
315. Deputy Richard Boyd Barrett asked the Minister for Health if she is aware of the cohort of women who are unable to take HRT due to a history of breast cancer, but for whom the drug veoza provides essential relief from vasomotor symptoms associated with menopause; if she will consider the inclusion of veoza in the drug payment scheme (DPS) as some women are being forced to abandon its usage given the prohibitive …
321. Deputy Jen Cummins asked the Minister for Health the specific steps are being taken to ensure the HSE recognises the “time-critical” nature of Friedreich’s ataxia during the current price negotiations for skyclarys; and if she will make a statement on the matter. [22549/26]
366. Deputy Máire Devine asked the Minister for Health the status of her Department's plans regarding reimbursement of a medication for a rare, progressive neurological condition (details supplied); and if she will make a statement on the matter. [22734/26]
367. Deputy Máire Devine asked the Minister for Health the steps being taken to ensure the HSE recognises the time-critical nature of Friedrich's Ataxia during current price negotiations with a prescription drug manufacturer. [22735/26]
413. Deputy Barry Ward asked the Minister for Health if her attention has been drawn to calls to allow for the provision of veoza (fezolinetant) under the drug payment scheme; and if she will make a statement on the matter. [22853/26]
414. Deputy Barry Ward asked the Minister for Health the research carried out by her Department into the benefits of the use of veoza (fezolinetant) in the treatment of cancer patients; and if she will make a statement on the matter. [22854/26]
415. Deputy Barry Ward asked the Minister for Health the position regarding any engagement she has had with the HSE in relation to the proposal to allow for the provision of veoza (fezolinetant) under the drug payment scheme; and if she will make a statement on the matter. [22855/26]
416. Deputy Barry Ward asked the Minister for Health the position regarding any engagement she has had with an organisation (details supplied) or any other health group in relation to the proposal to allow for the provision of veoza (fezolinetant) under the drug payment scheme; and if she will make a statement on the matter. [22856/26]